What is the equivalent dose of Concerta (methylphenidate) 36 mg to Vyvanse (lisdexamfetamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Direct Dose Equivalency: Concerta 36mg to Vyvanse

There is no established direct dose equivalency between Concerta (methylphenidate) 36mg and Vyvanse (lisdexamfetamine), and these medications should not be converted using a simple mathematical formula. 1

Why Direct Conversion Is Not Recommended

These are fundamentally different stimulant classes with distinct pharmacological properties:

  • Concerta (methylphenidate): Blocks dopamine and norepinephrine reuptake
  • Vyvanse (lisdexamfetamine): A prodrug converted to dextroamphetamine, which causes direct release of dopamine and norepinephrine from presynaptic terminals

The FDA labeling for Concerta explicitly states that conversion from other methylphenidate regimens requires "clinical judgment" rather than fixed ratios 1. This principle applies even more strongly when switching between different stimulant classes.

Practical Switching Approach

When switching from Concerta 36mg to Vyvanse, start with Vyvanse 30mg once daily in the morning 2. This represents a conservative starting approach that prioritizes safety.

Rationale for this approach:

  • Vyvanse starting doses range from 20-30mg for treatment-naive patients 2
  • Concerta 36mg represents a moderate methylphenidate dose (equivalent to 10mg methylphenidate three times daily) 1
  • Starting at 30mg Vyvanse allows for upward titration in 10mg weekly increments to a maximum of 70mg 2

Titration Strategy:

  1. Week 1: Start Vyvanse 30mg once daily in the morning
  2. Week 2-6: Increase by 10mg weekly increments based on symptom response and tolerability
  3. Target range: Most patients respond between 30-70mg daily
  4. Monitor: ADHD symptoms, side effects (appetite suppression, insomnia, irritability, cardiovascular parameters)

Critical Caveats

Individual response is highly variable and unpredictable 3. Research demonstrates that approximately 70% of patients respond to methylphenidate, while nearly 90% respond to at least one stimulant when both methylphenidate and amphetamine classes are tried 4, 3. This means some patients who respond well to Concerta may not respond optimally to Vyvanse, and vice versa.

The 12-hour duration of both medications does not mean equivalent dosing 4, 5. Concerta uses an osmotic release system creating an ascending plasma level, while Vyvanse is a prodrug with slow onset and sustained release 4, 5.

Monitoring Requirements

After switching, assess weekly during titration for:

  • Efficacy: ADHD symptom control using standardized rating scales
  • Safety: Blood pressure, pulse, weight, sleep quality, appetite, mood changes
  • Tolerability: Agitation, insomnia, decreased appetite (most common side effects) 6

If inadequate response occurs after reaching Vyvanse 70mg with appropriate trial duration, consider switching back to methylphenidate or trying alternative ADHD medications 7.

Related Questions

What is the equivalent dose of methylphenidate (Metadate) 40 mg taken once daily to lisdexamfetamine (Vyvanse)?
What ADHD medications are appropriate for a patient who had a craniotomy for an arteriovenous malformation (AVM) last year?
In a 13‑year‑old with attention‑deficit/hyperactivity disorder, should treatment begin with a stimulant or a non‑stimulant, and what are the recommended dosing and monitoring considerations?
In a 58-year-old woman with adult ADHD and atypical chest pain who is intolerant to atomoxetine, which of methylphenidate, lisdexamfetamine, or guanfacine has the safest cardiac safety profile?
What is the recommended clinical assessment and first‑line pharmacologic treatment for attention‑deficit/hyperactivity disorder (ADHD)?
What is the appropriate diagnostic approach to rule out scabies (Sarcoptes scabiei)?
Are the listed laboratory results (glucose 78 mg/dL, calcium 8.6 mg/dL, creatinine 1.00 mg/dL, BUN 21.6 mg/dL, BUN/creatinine ratio 21.6, sodium 138 mmol/L, potassium 3.7 mmol/L, chloride 102 mmol/L, carbon dioxide 23 mEq/L, anion gap 13, calculated osmolality 276.8 mOsm/kg, eGFR 77 mL/min/1.73 m²) within normal limits, and what, if any, clinical actions are indicated?
What is the oral onset of action time for gabapentin?
How much aspirin is in two Excedrin (acetaminophen/aspirin/caffeine) tablets?
What is the optimal first‑line antihypertensive medication for an otherwise healthy adolescent with newly diagnosed hypertension?
Is it safe to decrease fluoxetine from 60 mg to 40 mg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.